Abrilumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Abrilumab Usage And Synthesis

Uses

Abrilumab is a fully human monoclonal antibody directed against α4β7. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD)[1].

References

[1] Iris Dotan, et al. The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies. Med Res Rev DOI:10.1002/med.21601
[2] Christopher A Lamb, et al. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. J Crohns Colitis. 2018 Aug 22;12(suppl_2):S653-S668. DOI:10.1093/ecco-jcc/jjy060

Abrilumab(1342290-43-0)Related Product Information

• Romosozumab
• Caplacizumab
• Emapalumab
• Denosumab
• Sirukumab
• Emibetuzumab
• Lenzilumab
• IMMunoglobulin G2
• Immunoglobulin G 1 (human-mouse monoclonal BIWA4 gamma1-chain antihuman antigen CD44v8), disulfide with human-mouse monoclonal BIWA4 gamma-chain, dimer
• Motavizumab